Hua Lu

13.1k total citations · 1 hit paper
225 papers, 10.1k citations indexed

About

Hua Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hua Lu has authored 225 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Molecular Biology, 98 papers in Oncology and 36 papers in Cancer Research. Recurrent topics in Hua Lu's work include Cancer-related Molecular Pathways (89 papers), RNA modifications and cancer (45 papers) and Ubiquitin and proteasome pathways (39 papers). Hua Lu is often cited by papers focused on Cancer-related Molecular Pathways (89 papers), RNA modifications and cancer (45 papers) and Ubiquitin and proteasome pathways (39 papers). Hua Lu collaborates with scholars based in United States, China and South Korea. Hua Lu's co-authors include Mu‐Shui Dai, Shelya X. Zeng, Xiang Zhou, Yanping Zhang, Yetao Jin, Arnold J. Levine, Jun‐Ming Liao, Xiao‐Xin Sun, Peng Liao and Qian Hao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Hua Lu

216 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ribosomal proteins: functions beyond the ribosome

2015 488 citations Xiang Zhou, Wenjuan Liao et al. profile →

Peers

Countries citing papers authored by Hua Lu

Since Specialization

Citations

This map shows the geographic impact of Hua Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Lu more than expected).

Fields of papers citing papers by Hua Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Lu. The network helps show where Hua Lu may publish in the future.

Co-authorship network of co-authors of Hua Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Lu. A scholar is included among the top collaborators of Hua Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Lu. Hua Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of lipid metabolism-related diagnostic biomarkers and construction of diagnostic model in steroid-induced osteonecrosis of femoral head 2025 ·Open Medicine ·Bin Zuo, Zhanchao Wang, Hua Lu, Hao Shen	0
2	Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21-P27KIP1-mTOR axis 2025 ·The EMBO Journal ·(unknown), Hua Lu, Yao Liu, Jiabei Wang, Qunke Xia, (unknown), (unknown), (unknown), Wei Wang, Xiaopeng Ma, (unknown), Meng Gong, Canjun Li, Chunlei Cang, Qinghua Cui, Ceshi Chen, (unknown), Lianxin Liu, Xiangting Wang	3
3	Anti-cancer small-molecule Inauhzin-C confines its cytotoxicity to cancer cells by targeting GRP78 2025 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), Daniel Nguyen, Shelya X. Zeng, (unknown), Hua Lu	0
4	Identify Non-mutational p53 Functional Deficiency in Human Cancers 2024 ·Genomics Proteomics & Bioinformatics ·Qianpeng Li, Yang Zhang, Sicheng Luo, Zhang Zhang, Ann L. Oberg, David Kozono, Hua Lu, Jann N. Sarkaria, Lina Ma, Liguo Wang	0
5	Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth 2021 ·Cancer Research ·Jieqiong Wang, Yajie Chen, Canhua Huang, Qian Hao, Shelya X. Zeng, (unknown), Yu Zhang, Xiang Zhou, Hua Lu	13
6	Dual effects of thyroid hormone on neurons and neurogenesis in traumatic brain injury 2020 ·Cell Death and Disease ·Chao Lin, Nan Li, (unknown), (unknown), Zheng Li, (unknown), (unknown), Hua Lu, Jing Ji, Ning Liu	35
7	The clinical significance of indeterminate pulmonary nodules in melanoma patients at baseline and during follow-up chest CT 2019 ·European Journal of Radiology Open ·(unknown), Teresa M. Petrella, Pascal N. Tyrrell, Frances C. Wright, Nicole J. Look Hong, Hua Lu, Petros Zezos, Laura Jiménez‐Juan, Anastasia Oikonomou	10
8	Arl13b Promotes Gastric Tumorigenesis by Regulating Smo Trafficking and Activation of the Hedgehog Signaling Pathway 2017 ·Cancer Research ·Jia Shao, Linlin Xu, Limin Chen, Quqin Lu, Xinsheng Xie, Wei Shi, (unknown), Chao Shi, Xuan Huang, (unknown), Hai Rao, Hua Lu, Nonghua Lü, Shiwen Luo	34
9	Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism 2017 ·Scientific Reports ·Wenjuan Liao, Hongbing Liu, Yiwei Zhang, Ji Hoon Jung, Jiaxiang Chen, Xiaohua Su, Yeong C. Kim, Elsa R. Flores, San Ming Wang, Malwina Czarny‐Ratajczak, Wen Li, Shelya X. Zeng, Hua Lu	19
10	Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity 2017 ·Human Molecular Genetics ·(unknown), (unknown), Kwan Young Lee, Auinash Kalsotra, Hee Jung Chung, Hua Lu, Nien‐Pei Tsai	13
11	Inauhzin(c) Inactivates c-Myc Independently of p53 2015 ·Cancer Biology & Therapy ·Ji Hoon Jung, Jun‐Ming Liao, Qi Zhang, Shelya X. Zeng, Daniel Nguyen, Qian Hao, Xiang Zhou, Bo Cao, Sung‐Hoon Kim, Hua Lu	13
12	Differential scanning calorimetric evaluation of human meibomian gland secretions and model lipid mixtures: Transition temperatures and cooperativity of melting 2013 ·Chemistry and Physics of Lipids ·Hua Lu, Jadwiga C. Wojtowicz, Igor A. Butovich	22
13	Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth 2012 ·Cancer Biology & Therapy ·Yiwei Zhang, Qi Zhang, Shelya X. Zeng, Yu Zhang, Lindsey D. Mayo, Hua Lu	24
14	AQP2 is necessary for vasopressin- and forskolin-mediated filamentous actin depolymerization in renal epithelial cells 2011 ·Biology Open ·Naofumi Yui, Hua Lu, Richard Bouley, Dennis Brown	31
15	A role for SSRP1 in recombination‐mediated DNA damage response 2009 ·Journal of Cellular Biochemistry ·Anuradha Kumari, Olga M. Mazina, Ujwal Shinde, Alexander V. Mazin, Hua Lu	35
16	Human SSRP1 Has Spt16-dependent and -independent Roles in Gene Transcription 2007 ·Journal of Biological Chemistry ·Yanping Li, Shelya X. Zeng, Igor Landais, Hua Lu	58
17	Interferon-Inducible Protein IFIXα1 Functions as a Negative Regulator of HDM2 2006 ·Molecular and Cellular Biology ·Yi Ding, (unknown), Hua Lu, Mong‐Hong Lee, (unknown)	36
18	UV Induces p21 Rapid Turnover Independently of Ubiquitin and Skp2 2006 ·Journal of Biological Chemistry ·Hunjoo Lee, Shelya X. Zeng, Hua Lu	47
19	Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition 2004 ·Molecular and Cellular Biology ·Mu‐Shui Dai, Shelya X. Zeng, Yetao Jin, Xiao‐Xin Sun, Larry L. David, Hua Lu	409
20	MDM2 Suppresses p73 Function without Promoting p73 Degradation 1999 ·Molecular and Cellular Biology ·Xiaoya Zeng, Lihong Chen, Christine A. Jost, Ruth Maya, David M. Keller, Xinjiang Wang, William G. Kaelin, Moshe Oren, Jiandong Chen, Hua Lu	289

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact